Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment

Autor: Scharton, Dionna, Bailey, Kevin W., Vest, Zachary, Westover, Jonna B., Kumaki, Yohichi, Van Wettere, Arnaud, Furuta, Yousuke, Gowen, Brian B.
Zdroj: In Antiviral Research April 2014 104:84-92
Databáze: ScienceDirect